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To the Editor: 
Southeast Asian Ovalocytosis (SAO) is an autosomal dominant inherited red blood 
cell (RBC) membrane disorder caused by the heterozygous deletion of codons 400–408 in 
SLC4A1/Band 3/Anion Exchanger 1 (AE1)1. This deletion leads to misfolding of the protein, 
creating an inactive anion-transporter and altering the mechanical stability of the RBCs. 
Heterozygous SAO is characterized by the presence of stomatocytes, theta cells (RBCs with 
two stomas), macro-ovalocytes and ≥25% ovalocytes in the peripheral blood smears2. 
Although heterozygous SAO carriers are generally asymptomatic, homozygous SAO was 
considered to be lethal3. However, one successful birth of a homozygous SAO individual, 
born to asymptomatic heterozygous SAO Comorian parents, was reported in 2014 showing 
an association with severe dyserythropoietic anemia4. Here, we report the birth of five 
unrelated homozygous SAO babies in Malaysia showing that homozygous SAO is not as rare 
as previously thought. These babies belong to an SAO cohort collected from January 2007 to 
March 2020 at Universiti Sains Malaysia (USM), which includes a total of 68 patients. The 
study was instigated to further understand the physiological implications of heterozygous 
SAO within the Malay population. The detection of numerous homozygous SAO births has 
highlighted the need for the development of good practice to support the survival of these 
babies. 
SAO has a distinctive geographical distribution, occurring mostly in areas of 
Southeast Asia including neighboring regions of the Malay Peninsula, coastal regions of 
Papua New Guinea, Thailand, Indonesia, Taiwan and even Madagascar in the western Indian 
Ocean5,6. Investigations into the high incidence of SAO in malarious areas revealed that the 
SAO mutation confers protection from severe malaria caused by Plasmodium vivax and 
Plasmodium falciparum7,8.  
AE1 is the most abundant RBC membrane protein and mediates the efficient transport 
of carbon dioxide in the blood1. Heterozygous SAO individuals have only 50% normal RBC 
anion transport activity and thus less efficient gas transport. The heterozygous expression of 
the SAO AE1 in the red cell membrane not only affects the folding and structure of AE1 but 
also affects the structure of other red cell membrane proteins depressing a relatively high 
number of red cell antigens9. Neonatal anemia has also been reported in SAO families2. 
A truncated form of AE1 is expressed in the alpha-intercalated cells of the kidneys 
and is essential for acid secretion in the urine1. Loss of AE1 anion-transport activity in the 
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kidney causes distal renal tubular acidosis (dRTA) and occurs when AE1 expression is 
severely reduced as in hereditary spherocytosis (HS)10,11 or when kidney AE1 activity is 
severely reduced1 or trafficking of kidney AE1 is impeded in the alpha-intercalated cell1. 
Many dRTA mutations are recessive. When SAO AE1 is inherited in trans to a recessive 
dRTA AE1 mutation then the compound heterozygote will completely lack AE1 anion 
transport activity. This phenomenon explains the prevalence of dRTA in South East Asia 
where there are a number of recessive dRTA AE1 mutations maintained in the population12.  
Homozygous SAO individuals, with no functioning AE1, and homozygous HS 
individuals, with no AE1, suffer from hemolytic anemia, dRTA and failure to thrive3,10,11. An 
in-depth study of homozygous SAO cells13, showed expression of SAO AE1 during 
erythropoiesis (in vitro) affected trafficking and cytokinesis resulting in numerous 
multinucleated erythroblasts and reduced proliferation and enucleation. Unexpectedly, even 
the in vitro cultured heterozygous SAO erythroblasts displayed multinuclearity and reduced 
enucleation, with an intermediate phenotype part-way between the homozygous and control 
cells13, suggesting that heterozygous SAO individuals may have a mild dyserythropoiesis. 
Mature homozygous SAO RBCs show signs of altered membrane composition, oxidative 
damage, are very large, oval and unstable4,13. AE1 null HS individuals sometimes have a mild 
dyserythropoiesis10 and their RBCs are unstable11. Extensive clinical management of AE1 
null individuals, including splenectomy, has improved the survival of these children, some of 
whom have now reached adolescence. Similarly, the Comorian homozygous SAO child is 
now 10 years old and quite well, with regular transfusions, iron chelation and acidosis 
treatment4,13. From Malaysia, a live-born homozygous SAO neonate with dRTA was reported 
in 2015 but the child failed to thrive after two years14.  
In Malaysia, where the prevalence of SAO is around 4% within the Malay ethnic 
group15, SAO diagnostic tests are performed mostly upon still birth or recurring miscarriages 
of the mother. Several heterozygous SAO mothers in this cohort have a history of past 
miscarriages and complications during pregnancy such as hydrops fetalis as well as 
intrauterine death (Figure 1). Furthermore, SAO was identified in 18 of 22 dRTA patients 
(81.8%) when the association between SAO and dRTA was studied in the Malaysian dRTA 
cohort15. Here, we provide an overview of a Malaysian heterozygous SAO cohort and 
describe the clinical characteristics of five live-born homozygous SAO cases in Malaysia.  
This SAO cohort includes a total of 107 patients whose blood samples were tested for 
the 27 base pair deletion of AE1 using polymerase chain reaction (PCR) and blood smears 
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(Supplementary file and Supplement table 1). Among the 107 tested patients, 68 cases were 
positive where 93% (63 out of 68 cases) of SAO positive cases belonged to Malay ethnicity. 
Within this Malaysian SAO cohort, 81 cases studied belong to a total of 28 families. Among 
these 28, 23 families had at least one heterozygous SAO family member. The remaining 26 
samples were from individual cases, of which 15 were heterozygous SAO. The majority of 
the SAO positive cases (43%, n=29) are from Penang, followed by Kuala Lumpur (22%, 
n=15), Johor (10%, n=7), Sabah (9%, n=6), Kedah (9%, n=6), and Melaka (7%, n=5) 
(Supplement figure 3). A variety of RBC morphology were observed from peripheral blood 
film examination of the SAO positive cases, which includes macro-ovalocytes, stomatocytes, 
theta cells, spherocytes and target cells (Supplement table 1 and Supplement figure 1). 
Surprisingly, a total of six homozygous SAO were found in our cohort, five of whom 
were live-born (Figure 1, Table 1, Supplementary file, and Homozygous SAO case histories). 
All parents of live-born homozygous SAO cases, with the exception of one (GO 009/16), 
were confirmed heterozygous for the SAO AE1 deletion; case GO 012/19 was a homozygous 
fetus that suffered intrauterine death at 29 weeks. All the five live-born cases were delivered 
prematurely, in 30 to 35 weeks of gestation. Similar to previous homozygous SAO live-
borns, our five homozygous SAO live-borns suffered a severe phenotype requiring intra-
uterine transfusions, post-delivery transfusions and ventilation support. Despite efforts to 
manage their condition, two of the five patients reported here died, one during the neonatal 
period and one at two months. Even though the other two cases survived during the neonatal 
period, one of them (GO 012/13) had succumbed during infancy due to complications of 
anemia and the other is not traceable after two months. Further detail of obstetric history of 
these families are provided in Figure 1 and Supplement table 2. 
Among the five live-born homozygous SAO cases, three of them had severe anemia at 
birth and two of them developed it at 26 (GO/01/10) and 25 weeks (GO 012/13). All except 
GO 001/14 had hydrops fetalis and hepatosplenomegaly (Table 1). Physical examination 
revealed pale appearance, distended abdomen due to hepatosplenomegaly, and jaundice in all 
five cases. One of the five cases was reported to have dRTA diagnosed in the third month14 
but the other four were not tested. Despite medical interventions, all five homozygous SAO 
children failed to thrive. This could be due to hepatosplenomegaly, severe anemia or lack of 
appropriate clinical management. It is difficult to gain more insights into the implications of 
the SAO homozygous cases as incomplete clinical data of the SAO cohort was collected, 
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lacking data on hemoglobin abnormalities and blood group compatibility. It is also not known 
whether prenatal diagnosis and termination of pregnancy were offered. These services are not 
always available, and/or not acceptable to parents. It is now evident that careful clinical 
management can improve the life of homozygous SAO individuals4. The long-standing 
assumptions that homozygous SAO is lethal, and that heterozygous SAO is asymptomatic 
should be reassessed.  
Several point mutations in AE1 that result in a wide range of complications have been 
reported, many of them leading to anemia and dRTA2,12. Hemolytic anemia is recorded in 
children with homozygous G701D or compound heterozygous G701D/SAO, V850/SAO, 
A858D/SAO and V850/A858D mutations1. Therefore, homozygous SAO and other AE1 null 
individuals, who show disparity in survival, may be indicating the cumulative result of 
hemolysis, acidosis and other hematological abnormalities influenced by the co-occurrence of 
additional mutations.  
To our knowledge, this preliminary Malaysian SAO cohort study, for the first-time 
reports five homozygous SAO live-born cases. Since Malaysia and Southeast Asia have a 
high prevalence of SAO it would be beneficial to screen for SAO at antenatal clinics, at least 
for parents with a history of hydropic or stillborn fetuses. It is also essential to investigate the 
impact of heterozygous mutant SAO AE1 on other pathological conditions and ageing. 
Development of international and national guidelines for assessing a number of 
hematological, renal, and hepatic conditions in combination with genetic mutation markers to 
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Table 1: Comparison of five Malaysian live-born homozygous SAO cases with a previously reported Comorian homozygous SAO case. 
Case  GO 003/10 GO 010/10 GO 001/14 GO 009/16 GO 012/1314          Comorian SAO homozygote 4,13 
Gestation (weeks) 34 35 33 30 35 29 
Age at diagnosis Newborn 15 days old 3 months old Newborn 4 months old No data 
Gender Male Male Male Male  Male Male 
Race/Nationality Malay Malay Malay Malay Malay Comorian  
Living status 
Died at 6 hours of 
life 
Died at 2 months old Not known 
Died within few hours 
of life 
Died at 24 months 
old  
Alive, 10 years old    
(2020) 
Anaemia 
Severe anaemia at 
birth (Hb 4.9 g/dl) 
Severe anaemia at 26 
weeks gestation (Hb 
2.4 g/dl) 
Severe anaemia at 
birth (Hb 5.0 g/dl) 
Severe anaemia at birth 
(Hb 2.0 g/dl) 
Severe anaemia at 25 
weeks gestation (Hb 
3.0 g/dl); Hb 7.4 g/dl 
at 4 months old 
Severe anaemia at 22 
weeks gestation (Hb 
2.9 g/dl) 
Hydrops fetalis Yes Yes No Yes Yes Yes 
Hepatosplenomegaly Yes Yes No Yes Yes No data 
Physical 
examination 
Pale Bronzed                         Pale, jaundiced Very pale, born not 
vigorous, poor APGAR 
score, umbilical 
bleeding                             











neutrophilia.               
Many spherocytic 


















anaemia with marked 
reticulocytosis, NRBCs, 
many spherocytes and 
microspherocytes. Theta 




elliptocytes as well 



























Table 1, continued 






inotropic support).     
2. Packed cell 
transfusion after 
birth but died 
within few hours of 
life. 
1. Intrauterine 
transfusion twice due 
to fetal anaemia at 26 
weeks.                           
2. Ventilated after 
birth.                         
3. Packed cell 
transfusion at day 5 
of life.  
1. Ventilated after 
birth.                            
2. Exchange 
transfusion at 5 hours 
of life.                           
3. Six episodes of 
hemolysis within 42 
days of life (all 
required packed cell 
transfusion).                  
4. Hematinic 
prescribed. 
1. Ventilated after birth.   1. Intrauterine 
transfusion at 25 
weeks due to fetal 
anaemia and hydrops 
fetalis.                           
2. 2-weekly 
transfusions from 1 
month old.      
3. Developed renal 
tubular acidosis type 
I due to persistent 
metabolic acidosis 
and hypokalaemia.        
1. Montly 
transfusions since 
birth.                              
2. dRTA (3 months 
old) treated with oral 
sodium bicarbonate 
and potassium 
gluconate.                      
3. High ferritinemia 
(6 months old) treated 
with deferoxamine 
mesilate.                    












Figure 1: Family pedigree charts of five homozygous SAO cases. Families of each 
homozygous SAO cases are represented: (A) GO 003/10, (B) GO 001/14, (C) GO 010/10, 
(D) GO 012/19, and (E) GO 012/13. Squares and circles denote male and females, 
respectively, with filled ones (grey or black) showing members affected with SAO. The 
numbered triangle (C) shows number of spontaneous abortions that occurred in the couple’s 
past pregnancies. Parents of two SAO homozygous children (GO 012/19 and GO 010/10) had 
multiple unsuccessful pregnancies. The mother of GO 012/19 suffered two intrauterine deaths 
(including GO 012/19), while the mother of GO 010/10 suffered 3 spontaneous abortions. 
None of these other unsuccessful pregnancies were investigated further. On the other hand, 
parents of GO 012/13 have two living children among whom one is SAO heterozygous, while 
parents of GO 012/19 have three living children with unknown SAO status (see Supplement 









Between January 2007 and March 2020, a total of 108 (one in duplicate) samples were tested 
for the Southeast Asian Ovalocytosis (SAO) 27 base pair deletion of Band 3 using polymerase 
chain reaction (PCR) as previously described1. Briefly, genomic DNA was extracted from 
whole blood. The region containing the SAO 27 base pair deletion was amplified using forward 
primer 5' GGG CCC AGA TGA CCC TCT GC 3' and reverse primer 5' GCC GAA GGT GAT 
GGC GGG TG 3'. Three-step cycling was performed with initial denaturation at 94 °C for 1 
minute, followed by annealing at 63.5 °C for 1 minute, and extension at 72 °C for 3 minutes. 
The amplification step was repeated for 30 cycles followed by a final extension at 72 °C for 7 
minutes. The PCR products were separated on 2% agarose gels and visualized using ethidium 
bromide. Product sizes for normal and mutant Band 3 genes were expected to be 175 base pairs 
and 148 base pairs, respectively.   
For SAO diagnosis based on peripheral blood film method, a patient is considered SAO 
positive when there is a presence of ≥ 25% ovalocytes and stomatocytes on blood smears2,3. 
Patient records containing other clinical information were obtained from respective hospitals 
throughout Malaysia. In total, there were 62 heterozygous SAO cases, 6 homozygous SAO 
cases, and 28 families that were investigated. 
Ethics Statement: This study is an observation from the diagnostic cohort. Hence, fully 
anonymized audits are exempted from ethical review. 
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2. Supplementary figures and table 
 
Supplement figure 1: Representative images of peripheral blood film (PBF) using 
Wright’s stain with 40X magnification on patient GO 012/13 (A, B) and his parents (C, 
D). Blood smear on the homozygous SAO patient reveals the presence of elliptocytes, 
polychromasia, spherocytes/microspherocytes and small fragments pre-transfusion (A) 
whereas dimorphic features are seen post-transfusion (B). The PBF of both parents (C, D) show 
abundant macro-ovalocytes, stomatocytes, and knizocytes which are typical features of SAO.  
 
 
Supplement figure 2: Representative image of SAO Band 3 mutation detection with PCR 
on patient GO 001/14 and his parents. The SAO mutation was analyzed by amplification of 
exon 11 of SLC4A1 gene by PCR followed by electrophoresis on 2% agarose gel. Sample that 
does not have the 27 bp deletion in Band 3 will give a distinct band of 175 bp as shown in lane 
3 (L3), the normal control. Heterozygous SAO samples will give two distinct bands at 175 bp 
and 148 bp, whereas homozygous SAO will give one distinct band at 148 bp. Sample from 
patient GO 001/14 shows homozygosity (L5), while the parents are heterozygous SAO carriers 
(L6–L7).  Lane 1 (L1), standard DNA markers; Lane 2 (L2), negative control.   
 
Supplement figure 3: Geographical locations of cases tested positive for SAO in Malaysia between January 2007 and March 2020.   
 
 
Supplement table 2: Family history of homozygous SAO cases. 
 
Case GO 003/10 GO 010/10 GO 012/13 GO 001/14 GO 009/16 
GO 012/19 
(IUD) 































Living children None None 
1 with no SAO 







3 living children 
with unknown 
SAO status 
Total number of 
pregnancies including 
homozygous SAO 
1 4 3 1 1 5 
Number of deaths at 
infancy/neonatal period 
1 1 1 0 1 0 
Number of intrauterine 
deaths including 
homozygous SAO 
0 0 0 0 0 2 
Number of spontaneous 
abortions 
0 3 0 0 0 0 
Abbreviations: IUD, intrauterine death; SAO, Southeast Asian Ovalocytosis    
3. Homozygous SAO case histories 
 
Patient GO 003/10 
Patient GO 003/10 was a newborn Malay male delivered at 34 weeks of gestation by 
emergency caesarean section due to fetal distress. After birth, he required intubation and 
was admitted into the Intensive Care Unit with ventilatory and inotropic support. He 
appeared pale, had hepatosplenomegaly, and was also edematous while his chest X-ray 
results showed that he had a globular shaped heart. Full blood picture examination revealed 
the presence of abundant elliptocytes, stomatocytes, as well as nucleated red blood cells 
(NRBC). The patient also had neutrophilia and showed evidence of leucoerythroblastic 
picture as characterized by presence of numerous myelocytes and NRBCs. In addition, he 
had a low Hb concentration (4.9 g/dl; Normal range: 14–22 g/dl). Platelet count, on the 
other hand, was unremarkable. As such, the patient was diagnosed with hydrops fetalis 
secondary to hereditary stomatocytic-elliptocytosis and hemolysis; homozygous SAO was 
confirmed upon PCR analysis. Packed red cell transfusion was administered to the 
newborn, however, the patient succumbed to the condition at six hours of life. In terms of 
family history, both parents were tested heterozygous for the 27 base pair deletion in Band 
3. Also, their peripheral blood film examination showed typical SAO red blood cell 
morphology characterized by the presence of many elliptocytes and stomatocytes. Hence, 
both parents were diagnosed with hereditary stomatocytic-elliptocytosis with the father 
having mild leukocytosis. There was no history of consanguinity and patient GO 003/10 
was the couple’s first born child. 
  
Results from laboratory investigations of patient GO 003/10  
• Liver Function Test  
Total bilirubin    : 114 µmol/l (raised) – jaundiced 
Total protein (Normal: 66–83) : 59 g/l (reduced) 
Albumin (Normal: 35–52)  : 23 g/l (reduced)  
Globulin (Normal: 23–35)  : 3 g/l (reduced)  
ALT (Normal: <35)   : 51 U/L (raised)  
ALP (Normal: 30–120)  : 217 U/L (raised)  
• Calcium (Normal: 2.20–2.65)  : 3.0 mmol/l (slightly raised)  
• LDH (Normal: 140–280)  : 13418 U/L (raised) – hemolysis 
Patient GO 010/10 
Patient GO 010/10 was a 15 day old Malay male born at 35 weeks of gestation by 
emergency caesarean section due to fetal distress. At 26 weeks of gestation, fetal scan and 
doppler revealed an enlarged heart with pericardial effusions, oligohydramnios, and 
features of fetal anemia. Fetal anemia was confirmed when cordocentesis test showed low 
Hb concentration of 2.4 g/dl. Fetal transfusion in utero was then performed twice. After 
birth, the patient appeared bronzed, had large hepatomegaly (4–5 cm) and a palpable spleen 
(1 cm), which are signs of hydrops fetalis. The patient also suffered from respiratory 
distress and required ventilation. Peripheral blood film examination revealed RBCs that 
were either spherocytic, crenated, fragmented, or nucleated. Presence of reticulocytes were 
also observed while white blood cell count was unremarkable. However, he had slightly 
reduced platelet count but no clumping was observed. The patient had suffered from 
ongoing non-immune hemolytic anemia with jaundice. Exchange transfusion was 
performed at 2 days old followed by packed red cell transfusion at 5 days old, after which 
hemolysis had improved. Unfortunately, he succumbed to his condition at 2 months of age. 
Both the patient’s parents were tested heterozygous for the 27 base pair deletion in Band 3. 
Features of hereditary ovalostomatocytosis were also observed in their peripheral blood 
film examination. Interestingly, the mother had previously suffered three spontaneous 
abortions with a history of antenatal anemia; neither of the cases were fully investigated. 
Patient GO 010/10 was the first live-born child for the couple.  
 
Patient GO 012/13 
A detailed history of patient GO 012/13 has been reported by Asnawi et al., 2015. The 
patient was the first born for his parents. He failed to thrive with the condition and suffered 
developmental delay. He succumbed to his condition at 2 years of age. The parents 
subsequently had two other children; one with no SAO deletion in Band 3 and the other is 
SAO heterozygous. Both siblings are growing well with no evidence of hydrops fetalis or 
anemia.  
 
Patient GO 001/14 
Patient GO 001/14 was a 3 month old Malay male born prematurely at 33 weeks of 
gestation via spontaneous vaginal delivery. At birth, he weighed only 1.36 kg. He was 
severely pale and had signs of respiratory distress, which required ventilatory support. He 
was extubated at 18 hours of life and weaned to room air at day 4 of life. Physical 
examination had shown no dysmorphism, deformities, hepatosplenomegaly, features of 
hydrops, or cutaneous bleed. He did however have low Hb levels (5.0 g/dl) at birth. Packed 
cell transfusion was performed at 5 hours after birth and later he developed gross hematuria 
at 10 hours of life. Brain ultrasound showed bilateral grade I-II intraventricular 
hemorrhage. He was severely jaundiced with total bilirubin of 259–322 µmmol/l and LDH 
of 7482 U/L and hence required exchange transfusion. Within 42 days of life, he had 
suffered six episodes of hemolysis which required packed cell transfusions. His 
hemoglobin ranged between 8.5–9.3 g/dl and achieved 12.0 g/dl post-transfusion. The 
baseline hemoglobin was accepted between 8.0–9.0g/dl. Hematinic was commenced and 
continued. However, at day 55 and 85 days of life, his hemoglobin dropped again to 5.6 
g/dl and 5.9 g/dl, respectively. Full blood picture of both of his parents showed 
ovalostomatocytes with some macro-ovalocytes and theta cells. Sample from the infant 
showed hemolytic picture with spherocytosis, nucleated RBCs, and ovalostomatocytes. 
Coomb’s test excluded the possibility of the infant having hereditary spherocytosis. Upon 
PCR analysis, the parents were subsequently confirmed heterozygous carriers of SAO 
while the child was homozygous.  
 
Results from laboratory investigations of patient GO 001/14  
• Mean corpuscular volume (MCV): 143.9 fl  
• Reticulocyte:     12.9% 
• White cell count:    29.8  
• Platelet count:    242 
• G6PD:     Normal.  
• Kleihauer test, direct Coomb test, renal profile and coagulation profile was 
normal.  
• Liver Function Test revealed increasing trend of direct hyperbilirubinemia.  
 
Patient GO 009/16 
Patient GO 009/16 was a newborn Malay male born prematurely at 30 weeks of gestation. 
At birth, the infant was very pale, had distended abdomen, was not vigorous, and had poor 
APGAR score. The infant showed signs of hydrops fetalis and also suffered bleeding from 
the umbilicus. The infant required ventilatory support after birth. Unfortunately, the infant 
succumbed to the condition a few hours after delivery. Peripheral blood film examination 
on the patient sample showed spherocytosis with polychromasia, while the same 
examination was suggestive of SAO for both parents. However, SAO status of both parents 
was not confirmed with PCR.  
 
Patient GO 012/19 
Patient GO 012/19 is a case of intrauterine death at 29 weeks with the fetus showing signs 
of hydrops fetalis. The patient was male and of Malay ancestry. Both parents were tested 
heterozygous for SAO Band 3 deletion, with the father also being heterozygous for alpha 
plus thalassemia 3.7 kb deletion. This patient is the second intrauterine death for the couple. 
They have three living children, all of which have unknown SAO status as the children 
were not screened.  
 
 
Supplement table legend 
Supplement table 1: The clinical information of patients tested for 27 base pair deletion 
in Band 3 between January 2007- March 2020. In the table the abbreviations: "/", denotes 
presence; bp, base pair; D, days; F, female; IUD, intrauterine death; M, male; NA, not 
available; NB, newborn; NRBC, nucleated red blood cells; PBF, peripheral blood film; 
RBC, red blood cells; SAO, Southeast Asian Ovalocytosis; SB, stillbirth; U, unknown; Y, 
years 
 
